Therefore, we will extensively investigate the effects of CENP-N on other pathways in the future, hoping to lay the foundation for the use of nanomaterials to deliver CENP-N-targeting shRNA or other small molecule drugs for NPC radiotherapy. The gene discussed is CENPN; the disease is nasopharyngeal carcinoma.